John Ashley
Medical · Savannah, GANPI 1861569956
Payments from drug & device makers
Across 110 payments — averaging $22.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$637
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$618
- Boston Scientific$147
- Abbott$142
- E.r. Squibb & Sons, L.L.C.$126
- Cvrx, Inc.$116
- plus $670 from 13 others
What the payments were for
- Food & beverage$2,456100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 40 | $637 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 21 | $618 |
| Boston Scientific | 6 | $147 |
| Abbott | 2 | $142 |
| E.r. Squibb & Sons, L.L.C. | 7 | $126 |
| Cvrx, Inc. | 5 | $116 |
| Pfizer | 6 | $92 |
| Bayer | 1 | $92 |
| Abiomed | 1 | $86 |
| Johnson & Johnson | 5 | $68 |
| Cardiva Medical, Inc. | 3 | $67 |
| Medtronic | 4 | $67 |
| Shockwave Medical, Inc | 2 | $58 |
| AstraZeneca | 2 | $33 |
| Atricure, Inc. | 1 | $32 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Gilead | 1 | $21 |
| Merck | 1 | $16 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$231
- Confirm Rx$125
How this compares
$2,456 in reported general payments places this provider in the 70th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 74 | $51,525 |
| FarxigaDapagliflozin Propanediol | 52 | $31,265 |
| EntrestoSacubitril/Valsartan | 21 | $13,871 |
| BrilintaTicagrelor | 19 | $12,828 |
| Prasugrel Hcl | 21 | $1,456 |
| Atorvastatin Calcium | 76 | $700 |
| ClopidogrelClopidogrel Bisulfate | 75 | $668 |
| Metoprolol Succinate | 45 | $405 |
| Losartan Potassium | 39 | $284 |
| Rosuvastatin Calcium | 20 | $240 |
| Potassium Chloride | 19 | $229 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 16 | $209 |
| Amiodarone Hcl | 15 | $172 |
| Furosemide | 31 | $138 |
| Carvedilol | 20 | $122 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $92 | $51,52574 claims |
| AstraZenecaFarxiga, Brilinta | $33 | $44,09371 claims |
| NovartisEntresto | $637 | $13,87121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 950 medical providers in Georgia.
Other medical in Savannah
- Michael WhitledgeSavannah$12K
- Jordan HoustonSavannah$12K
- Kristy GierkeSavannah$11K
- Patricia EmfingerSavannah$10K
- Victoria FinlandSavannah$10K
- Jason SeymourSavannah$10K
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.